Sunday - May 18, 2025

Surf Air Mobility

Latest Medicinal Cannabis News


CV Sciences Reports First Quarter 2025 Financial Results

Last Trade: 0.03 -0.0029 -9.70

SAN DIEGO, CA / ACCESS Newswire / May 14, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended March 31, 2025. First Quarter 2025 and Recent Financial and Operating... Read more


MediPharm Labs Announces Strong Q1 2025 Results

Last Trade: 0.07 -0.006 -8.45

Achieves Positive Adjusted EBITDA(1) Revenue of $10.8 Million, an Increase of 11% over Q1 2024 87% Growth in International Medical Cannabis Revenue, Forming 55% of Total Revenue Gross Profit of $4.2 million, or 39% of Total Revenue, Improved Significantly over Q1 2024 Management to Host Conference Call / Webcast on May 14, 2025 at 10:00 am ET TORONTO, May 14, 2025 /CNW/ - MediPharm Labs Corp. (TSX:... Read more


FLUENT: Introducing Entourage: A B2B Wholesale Platform Serving the New York Cannabis Market

Last Trade: 0.05 -0.006 -10.71

Offering a Curated Portfolio of Brands Including MOODS, MOODS Black, and KNACK NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) --  FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), announces Entourage, a new wholesale cannabis platform serving licensed retailers across New York, officially launching with a curated portfolio of trusted and emerging brands. Developed in association with FLUENT,... Read more


TILT Holdings: Curaleaf International, in Partnership with Jupiter Research, Secures EU Medical Device Certification for Europe's First Handheld Liquid...

Last Trade: 0.004 -0.0025 -38.46

LONDON, May 12, 2025 /CNW/ -- Curaleaf International, part of Curaleaf Holdings, Inc. (TSX: CURA) in collaboration with Jupiter Research LLC, a subsidiary of TILT Holdings Inc. ("TILT") (Cboe CA: TILT) (OTCPK: TLLTF), has secured regulatory approval for the first handheld liquid inhalation device designed for precise medical cannabis administration. This EU medical device certification (Regulation (EU) 2017/745)... Read more


Innocan Pharma First Granted Patent in Mexico for its Topical Pain Relief

Last Trade: 0.16 0.00 0.00

Innocan's first fully-granted patent in Mexico Covers Innocan's proprietary cannabis-based pain relief topical Indication of Innocan's growing intellectual property portfolio HERZLIYA, Israel and CALGARY, AB, May 6, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is... Read more


Tilray Medical Introduces Cannabis Edibles in Australia

Last Trade: 0.49 0.05 10.23

SYDNEY, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a global company in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, has announced the availability of its medical cannabis edibles, Good Supply Pastilles, to patients in Australia.... Read more


FLUENT Reports Fourth Quarter and Full Year 2024 Results

Last Trade: 0.05 -0.006 -10.71

TAMPA, Fla., April 17, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) ("FLUENT" or the "Company"), a vertically-integrated, multi-state cannabis company, today announced its financial and operating results for the fourth quarter and full year ended December 31, 2024. Unless otherwise indicated, all financial results are presented in U.S. dollars. Management Commentary "Closing out the year, we... Read more


FLUENT Introduces MOODS Black to Florida Market

Last Trade: 0.05 -0.006 -10.71

TAMPA, Fla., April 15, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), a national cannabis company operating under the FLUENT™ brand, proudly announces the launch of MOODS Black, an extension of its acclaimed MOODS lineup. Featuring cannabis-derived terpenes and high-potency cannabis oil, MOODS Black is crafted to deliver an elevated and authentic cannabis... Read more


Trulieve Cannabis to Open Medical Cannabis Dispensary in St. Petersburg, Florida

Last Trade: 4.44 -0.22 -4.72

New Pinellas County location will host grand opening celebration Friday, April 11th TALLAHASSEE, Fla., April 9, 2025 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in St. Petersburg, Florida. A grand opening celebration will be held... Read more


Body and Mind Lynwood IL Dispensary Grand Opening and Corporate Update

Last Trade: 0.007 0.00 0.00

Las Vegas, Nevada and Vancouver, British Columbia--(Newsfile Corp. - April 8, 2025) - Body and Mind Inc. (CSE: BAMM) (OTC Pink: BMMJ) (the "Company" or "BaM") is pleased to announce the Grand Opening event at the newly opened Lynwood Illinois dispensary. "We are excited to host the Grand Opening event on April 12th at 12:00 PM at our Lynwood dispensary conveniently, located at the corners of Glenwood Dyer Rd and... Read more


Innocan Pharma Broadens Intellectual Property Coverage for its Liposomal CBD Injection Across Asia and Announces Private Placement of Units

Last Trade: 0.16 0.00 0.00

Innovative Chronic Pain Treatment expand IP Protection in China's US$163 Billion Pharmaceutical Market HERZLIYA, Israel and CALGARY, AB, April 7, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that a divisional application for its Chinese (CN) liposome-based CBD... Read more


FLUENT Expands Hyer Kind Brand to the New York Market

Last Trade: 0.05 -0.006 -10.71

NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), a national cannabis company operating under the FLUENT™ brand, is proud to announce the launch of Hyer Kind, a cosmic voyage into the world of premium cannabis, in the state of New York. Hyer Kind’s expertly crafted live rosin-infused pre-rolls “Boosters” are now available at all adult-use FLUENT... Read more


Canopy Growth and Spectrum Therapeutics Announce Spectrum Reserve, A New Premium Medical Cannabis Brand

Last Trade: 1.66 0.32 23.88

New Brand Features Premium Genetics, Selected for Potency, Terpenes, and Consistency SMITHS FALLS, Ontario / Apr 02, 2025 / Business Wire / Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has launched Spectrum Reserve, a new premium medical cannabis brand in Canada. Designed to... Read more


1933 Industries Reports Second Quarter 2025 Financial Results

Last Trade: 0.007 0.002 40.00

VANCOUVER, BC / ACCESS Newswire / March 31, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF(OTC PINK:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce its second quarter financial results ("Q2 2025") for the three and six months ended January 31, 2025 and 2024 ("Fiscal 2025"). All amounts expressed are in Canadian dollars. The Company owns 91% of... Read more


MediPharm Labs Reports Full Year & Fourth Quarter 2024 Results

Last Trade: 0.07 -0.006 -8.45

Annual Net Revenue Increase of 27% to $42M, Driven by Record $18M International Medical Cannabis Revenue and Approaching Positive Adjusted EBITDA(1) for Q4. TORONTO, March 31, 2025 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, today announced its financial results for... Read more


Innocan Pharma Reports Full Year 2024 Results with Revenues more than Doubling to US $29.4 million

Last Trade: 0.16 0.00 0.00

HERZLIYA, Israel and CALGARY, AB, March 31, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies is pleased to announce its audited financial consolidated results for the year ended December 31, 2024. Full Year 2024 Financial Highlights Revenues... Read more


CV Sciences Reports Fiscal Year-End 2024 Financial Results

Last Trade: 0.03 -0.0029 -9.70

SAN DIEGO, CA / ACCESS Newswire / March 27, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the year and quarter ended December 31, 2024. Fiscal 2024, Fourth Quarter 2024 and Recent Financial and... Read more


Trulieve Cannabis to Open Medical Cannabis Dispensary in North Miami Beach, Florida

Last Trade: 4.44 -0.22 -4.72

New Miami-Dade County location will host grand opening celebration Friday, March 21st TALLAHASSEE, Fla., March 18, 2025 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in North Miami Beach, Florida. A grand opening celebration... Read more


Tilray Medical Launches Tilray Craft: Introducing High THC, High Terpene Genetics to the German Medical Cannabis Market

Last Trade: 0.49 0.05 10.23

NEUMÜNSTER, Germany, March 11, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming healthcare, is pleased to announce the introduction of Tilray Craft, a new brand... Read more


Cresco Labs to Operate Kentucky’s Largest Medical Cannabis Cultivation License

Last Trade: 0.68 -0.05 -7.52

CHICAGO / Mar 10, 2025 / Business Wire / Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced its management services agreement with a Tier 3 Cultivation License in Kentucky (the “Cultivation License”). The agreement entitles... Read more


PharmaCielo Reports Q4 2024 Financial Results

Last Trade: 0.04 0.00 0.00

PharmaCielo achieved 143% Year-Over-Year Sales Growth, Generating Year-to-Date Q4 Total Revenue of $3.54 Million. Revenues and Gross Profit Margin Increased with More Diverse Customer Base. Q4 Cash Flow Continued to Improve and Adjusted EBITDA Increased by $1.1 Million versus Last Year Reflecting Strong Sales Growth and Reduced Costs. Financial Year-End is March 31. Audited Financial Statements will be for the... Read more


Canopy Growth Announces Entry of Tweed Brand to German Medical Cannabis Market

Last Trade: 1.66 0.32 23.88

Four new Tweed strains available through an agreement with Portugal-based Gro-Vida Tweed Glitter Bomb strain launched in December 2024 through an agreement with German-based Cansativa SMITHS FALLS, ON, Feb. 27, 2025 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has... Read more


Village Farms Expands Medical Cannabis Distribution to New Zealand

Last Trade: 1.05 0.12 12.65

VANCOUVER, British Columbia, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF) today announced its first shipment to New Zealand through its wholly-owned subsidiary Pure Sunfarms. The shipment features Pink Kush, the top-selling dried flower strain over the past four years1 in Canada, the largest federally legal market in the world. Pink Kush,... Read more


Florida's Premier Medical Marijuana Provider FLUENT™ Relocates North Miami Beach location to Aventura

Last Trade: 0.05 -0.006 -10.71

Offering a new, expanded and improved retail experience for Miami residents.  TAMPA, Fla., Feb. 27, 2025 /CNW/ - FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) ("FLUENT" or the "Company"), a vertically-integrated, multi-state cannabis company operating under the FLUENT™ brand, today announced the relocation of its Miami dispensary from North Miami Beach to Aventura. Patients with a valid medical marijuana... Read more


1933 Industries Announces First Quarter 2025 Financial Report

Last Trade: 0.007 0.002 40.00

VANCOUVER, BC / ACCESS Newswire / February 27, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTC PINK:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce its first quarter financial results ("Q1 2025") for the three months ended October 31, 2024 and 2023. All amounts expressed are in Canadian dollars. The Company owns 91% of Alternative Medicine... Read more


1933 Industries Announces Fourth Quarter and 2024 Year-End Financial Results with Record Revenues of $19.3 Million

Last Trade: 0.007 0.002 40.00

VANCOUVER, BC / ACCESS Newswire / February 25, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF) (OTC PINK:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce its fourth quarter ("Q4 2024") and audited annual financial results for the years ended July 31, 2024 and 2023 ("Fiscal 2024"). All amounts expressed are in Canadian dollars. The Company owns 91% of... Read more


Charlotte's Web Holdings: DeFloria Receives Investigational New Drug Application Clearance from FDA for Phase 2 Clinical Trial of AJA001, an Oral Cannabinoid...

Last Trade: 0.09 -0.007 -7.00

DeFloria plans to initiate a Phase 2 clinical trial by mid-year 2025 LITTLETON, Colo., Feb. 24, 2025 /PRNewswire/ -- DeFloria, Inc., a collaboration between Ajna BioSciences PBC and Charlotte's Web Holdings, Inc. (TSX: CWEB, OTCQX: CWBHF), announced that the U.S. Food and Drug Administration (FDA) has completed its review of the Investigational New Drug (IND) application for AJA001, an orally delivered,... Read more


Aurora Cannabis Expands Medical Cannabis Pastille Offerings in Australia

Last Trade: 5.13 1.28 33.25

Canada's Leading Medical Cannabis Company Broadens Innovative Product Portfolio to Growing Market in Australia EDMONTON, AB, Feb. 20, 2025 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, has announced today the company's extended pastille offerings in Australia. This expansion marks another meaningful step in Aurora's deep commitment to... Read more


Breaking Down Barriers: Aurora Cannabis Eases Patient Access to High Quality Medical Cannabis Products in Australia

Last Trade: 5.13 1.28 33.25

Largest Global Medical Cannabis Company Operating in Nationally Regulated Markets, Aurora Removes Concession Card Requirements to Access IndiMed Products in Australia EDMONTON, AB, Feb. 14, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, in conjunction with MedReleaf Australia, recently removed the... Read more


Tilray Expands Medical Cannabis Portfolio in Germany

Last Trade: 0.49 0.05 10.23

NEUMÜNSTER, Germany, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, is pleased to announce the expansion of its industry-leading medical cannabis extract portfolio in... Read more


Innocan Pharma's Liposomal CBD Injection Shows Breakthrough Pain Relief in Elderly Donkey with Osteoarthritis

Last Trade: 0.16 0.00 0.00

This is the second successful treatment in a donkey, demonstrating the potential of Innocan's Liposomal CBD injection for human and veterinary use HERZLIYA, Israel and CALGARY, AB, Feb. 10, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce the successful outcome... Read more


Body and Mind Announces Sale of Illinois Assets and Provides Corporate Update

Last Trade: 0.007 0.00 0.00

Las Vegas, Nevada and Vancouver, British Columbia--(Newsfile Corp. - January 30, 2025) - Body and Mind Inc. (CSE: BAMM) (OTC Pink: BMMJ) (the "Company" or "BaM") is pleased to announce that it has entered into definitive agreements for the sale of its Illinois assets, NMG IL 1, LLC ("NMG IL 1") and NMG IL 4, LLC ("NMG IL 4") to Rubino Ventures IL, LLC d/b/a/ Dutchess Cannabis, an Illinois cannabis company which... Read more


Trulieve Cannabis to Open Medical Cannabis Dispensary in Palm Coast, Florida

Last Trade: 4.44 -0.22 -4.72

New Flagler County location will host grand opening celebration Friday, January 31st TALLAHASSEE, Fla., Jan. 27, 2025 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in Palm Coast, Florida. A grand opening celebration will be... Read more


Aurora Cannabis Launches First Domestically Grown Medical Cannabis Brand in Germany Under New Cultivation License

Last Trade: 5.13 1.28 33.25

Investment in the region continues with the launch of IndiMed, the company's first locally grown brand in Germany EDMONTON, AB, Jan. 23, 2025 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces today the launch of the company's first German-cultivated medical cannabis product, under the brand IndiMed. Manufactured at Aurora's leading... Read more


MediPharm Labs Provides Update on Previously Announced Sale of Napanee Facility to Kensana Health

Last Trade: 0.07 -0.006 -8.45

TORONTO, Jan. 16, 2025 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) ("MediPharm", "MediPharm Labs" or the "Company") is pleased to provide an update with respect to the previously announced sale of its facility in Napanee, Ontario (the "Napanee Facility") to be completed pursuant to the terms of a share purchase agreement (the "Purchase Agreement") entered into with Kensana Health Inc.... Read more


High Tide to Enter German Medical Cannabis Market Through Acquisition of Purecan GmbH

Last Trade: 2.36 0.05 2.16

Acquisition Will Give High Tide Majority Stake in Purecan's Profitable Operations, German Import License, Warehousing and Logistics Infrastructure, and In-Development Telemedicine Portal The Company Intends to Leverage its Procurement Expertise and Licensed Producer Relationships Associated with its over $1.5 Billion Cumulative Canadian Brick & Mortar Cannabis Sales to Supply the German Medical Cannabis... Read more


MediPharm Labs Enters Landmark Commercial Agreement with Laboratório Teuto in Brazil

Last Trade: 0.07 -0.006 -8.45

MediPharm Labs expands its Brazilian presence where the medical cannabis market is estimated to be worth $198 million in 2024, serving over 670,000 patients.1 Products include full-spectrum, GMP sublingual oral solutions with extensive pharmaceutical validation and characterization. Teuto is one of Brazil's largest pharmaceutical manufacturers of both generic and branded medicines, with an extensive portfolio... Read more


Cansortium: FLUENT Unveils Bag-O: A New Value Brand for Florida Medical Marijuana Patients, Launching January 7

Last Trade: 0.05 -0.006 -10.71

TAMPA, Fla., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Cansortium Inc. (CSE: TIUM.U) (OTCQB: CNTMF) (“Cansortium” or the “Company”), a vertically integrated, multi-state cannabis company operating under the FLUENT™ brand, today announces the launch of Bag-O, a new value-focused line of premium cannabis flower, available to Florida medical marijuana patients starting January 7. With an emphasis on quality and affordability,... Read more


Tilray Medical Wins Tender to Supply Luxembourg with Medical Cannabis

Last Trade: 0.49 0.05 10.23

NEUMÜNSTER, Germany, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), proudly announces that its German subsidiary, Tilray Deutschland GmbH, has secured a tender to supply Luxembourg with its high-quality cannabis flower. The granting of this tender by the Ministry of Health and Social Security for the Grand Duchy of Luxembourg highlights the trust... Read more


Aurora Cannabis Announces Distribution Partnership Between MedReleaf Australia and The Entourage Effect

Last Trade: 5.13 1.28 33.25

The collaboration aims to broaden access of premium medical cannabis products to Australian patients EDMONTON, AB, Dec. 17, 2024 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce a distribution partnership between The Entourage Effect and MedReleaf Australia. The Entourage Effect provides comprehensive distribution and... Read more

COPYRIGHT ©2025 GREEN STOCK NEWS